DexCom Inc. (DXCM)

136.86
NASDAQ : Health Technology
Prev Close 146.25
Day Low/High 135.22 / 156.16
52 Wk Low/High 53.30 / 156.16
Avg Volume 1.31M
Exchange NASDAQ
Shares Outstanding 88.84M
Market Cap 12.99B
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Dexcom Schedules Fourth Quarter And Full Year 2018 Earnings Release And Conference Call For February 21, 2019 At 4:30 P.m. Eastern Time

Dexcom Schedules Fourth Quarter And Full Year 2018 Earnings Release And Conference Call For February 21, 2019 At 4:30 P.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2018 financial results after market close on Thursday, February 21, 2019.

Tumultuous, but Positive: Cramer's 'Mad Money' Recap (Friday 1/11/19)

Tumultuous, but Positive: Cramer's 'Mad Money' Recap (Friday 1/11/19)

This will be the craziest reporting season we've seen in ages, says Jim Cramer. He's got your game plan for next week.

Take-Two Interactive, Cliffs Natural Resources: 'Mad Money' Lightning Round

Take-Two Interactive, Cliffs Natural Resources: 'Mad Money' Lightning Round

Jim Cramer takes a look at Take-Two Interactive, Sina, Cliffs Natural Resources, Public Service Enterprise, Annaly Capital, Neutral Tandem and more.

From Bear Back to Bull: Cramer's 'Mad Money' Recap (Thursday 1/10/19)

From Bear Back to Bull: Cramer's 'Mad Money' Recap (Thursday 1/10/19)

Jim Cramer says it looks like the bulls are no longer fighting the Fed or the tape.

Buy Before the Bad News Ends: Cramer's 'Mad Money' Recap (Wednesday 1/9/19)

Buy Before the Bad News Ends: Cramer's 'Mad Money' Recap (Wednesday 1/9/19)

You can't wait. You have to buy ahead of the end of bad news. Jim Cramer puts this market action in context.

Dexcom Reports Record Preliminary, Unaudited Revenue For The Fourth Quarter And Fiscal Year 2018 And Provides Initial 2019 Outlook

Dexcom Reports Record Preliminary, Unaudited Revenue For The Fourth Quarter And Fiscal Year 2018 And Provides Initial 2019 Outlook

DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring ("CGM"), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2018 to exceed $331 million, an increase of at least 50% over the...

Dexcom Announces Upcoming Conference Presentation

Dexcom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Kevin Sayer, Chairman, Chief Executive Officer and President, will present an update on the company at the J.

DexCom Announces Proposed Offering Of $750 Million Of Convertible Senior Notes

DexCom Announces Proposed Offering Of $750 Million Of Convertible Senior Notes

DexCom, Inc. (Nasdaq: DXCM) ("DexCom") announced today that it intends to offer, subject to market conditions and other factors, $750 million aggregate principal amount of Convertible Senior Notes due 2023 (the "notes") in a private placement to qualified...

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development and Matthew Dolan, Vice President,...

Dexcom And Verily Amend Collaboration And License Agreement

Dexcom And Verily Amend Collaboration And License Agreement

DexCom, Inc. ( NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), and Verily, an Alphabet company, announced an amendment to the Collaboration and License Agreement surrounding the ongoing development efforts between the companies.

Dexcom To Host Investor Day On December 4, 2018

Dexcom To Host Investor Day On December 4, 2018

DexCom, Inc. (NASDAQ:DXCM) today announced that it will host an Investor Day on December 4, 2018 at the Laguna Cliffs Marriott in Dana Point, California.

DexCom Reports Third Quarter 2018 Financial Results

DexCom Reports Third Quarter 2018 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended September 30, 2018.

Tech Doesn't Have Good Defense: Cramer's 'Mad Money' Recap (Thursday 9/6/18)

Tech Doesn't Have Good Defense: Cramer's 'Mad Money' Recap (Thursday 9/6/18)

Jim Cramer, celebrating the opening of the NFL season, says this is just another day of total tech mayhem.

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at PayPal, Senseonomics, Idexx Laboratories, Sonos, Denbury Resources, Apptio, Invitae, Wayfair, JD.com, and McDonald's.

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

Jim Cramer says Wall Street isn't very worried about tariffs. He highlights the stocks with China exposure and looks at the potential impact.

Dexcom G6® Continuous Glucose Monitoring System Will Be Available To Medicare Beneficiaries With Diabetes In Early 2019

Dexcom G6® Continuous Glucose Monitoring System Will Be Available To Medicare Beneficiaries With Diabetes In Early 2019

DexCom, Inc. ( NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today the new Dexcom G6 ® CGM System will be covered for Medicare beneficiaries, having met the category requirements for therapeutic CGM systems by the U.

DexCom Schedules Third Quarter 2018 Earnings Release And Conference Call For November 6, 2018 At 4:30 P.m. Eastern Time.

DexCom Schedules Third Quarter 2018 Earnings Release And Conference Call For November 6, 2018 At 4:30 P.m. Eastern Time.

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2018 financial results after market close on Tuesday, November 6, 2018.

Dexcom Acquires TypeZero Technologies

Dexcom Acquires TypeZero Technologies

DexCom, Inc. ( NASDAQ:DXCM), the leader in continuous glucose monitoring for people with diabetes, announced today that it has acquired TypeZero Technologies, Inc.

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Quentin Blackford, Executive Vice President and Chief Financial Officer, and Matthew Dolan, Vice President,...

DexCom Executive Chairman And Director Terry Gregg Retires

DexCom Executive Chairman And Director Terry Gregg Retires

DexCom, Inc. ( NASDAQ:DXCM), the leader in continuous glucose monitoring for people with diabetes, announced today that Terry Gregg has retired as the Company's Executive Chairman and from the Company's Board of Directors after 13 years with Dexcom.

DexCom Reports Second Quarter 2018 Financial Results

DexCom Reports Second Quarter 2018 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended June 30, 2018.

Weekly Roundup

An earnings heavy week also included progress on reducing trade tensions.

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development, and Quentin Blackford, Executive Vice...

The Three Bullish Charts of DexCom

The Three Bullish Charts of DexCom

With more gains likely on the charts let's come up with a strategy to take advantage of this opportunity.

Market Loves Fintech: Cramer's 'Mad Money' Recap (Thursday 7/19/18)

Market Loves Fintech: Cramer's 'Mad Money' Recap (Thursday 7/19/18)

Jim Cramer says financial payment companies are the most beloved in the market right now. He explains digitized payment companies. And love.

Top Analysts Say Gamble On These 3 Ace Stocks

Top Analysts Say Gamble On These 3 Ace Stocks

We've got a 'cheat sheet' for you. Here are the best names that have analysts cheering.

DexCom Schedules Second Quarter 2018 Earnings Release And Conference Call For August 1, 2018 At 4:30 P.m. Eastern Time.

DexCom Schedules Second Quarter 2018 Earnings Release And Conference Call For August 1, 2018 At 4:30 P.m. Eastern Time.

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2018 financial results after market close on Wednesday, August 1, 2018.

Industrials in Value Territory: Cramer's 'Mad Money' Recap (Thursday 6/21/18)

Industrials in Value Territory: Cramer's 'Mad Money' Recap (Thursday 6/21/18)

Jim Cramer says many stocks already reflect the worst-case scenarios, and that means he sees a lot of upside potential.

TheStreet Quant Rating: C (Hold)